Literature DB >> 26961545

CD40 Negatively Regulates ATP-TLR4-Activated Inflammasome in Microglia.

Sagar Gaikwad1, Divyesh Patel1, Reena Agrawal-Rajput2.   

Abstract

During acute brain injury and/or sterile inflammation, release of danger-associated molecular patterns (DAMPs) activates pattern recognition receptors (PRRs). Microglial toll-like receptor (TLR)-4 activated by DAMPs potentiates neuroinflammation through inflammasome-induced IL-1β and pathogenic Th17 polarization which critically influences brain injury. TLR4 activation accompanies increased CD40, a cognate costimulatory molecule, involved in microglia-mediated immune responses in the brain. During brain injury, excessive release of extracellular ATP (DAMPs) is involved in promoting the damage. However, the regulatory role of CD40 in microglia during ATP-TLR4-mediated inflammasome activation has never been explored. We report that CD40, in the absence of ATP, synergizes TLR4-induced proinflammatory cytokines but not IL-1β, suggesting that the response is independent of inflammasome. The presence of ATP during TLR4 activation leads to NLRP3 inflammasome activation and caspase-1-mediated IL-1β secretion which was inhibited during CD40 activation, accompanied with inhibition of ERK1/2 and reactive oxygen species (ROS), and elevation in p38 MAPK phosphorylation. Experiments using selective inhibitors prove indispensability of ERK 1/2 and ROS for inflammasome activation. The ATP-TLR4-primed macrophages polarize the immune response toward pathogenic Th17 cells, whereas CD40 activation mediates Th1 response. Exogenous supplementation of IFN-γ (a Th1 cytokine and CD40 inducer) results in decreased IL-1β, suggesting possible feedback loop mechanism of inflammasome inhibition, whereby IFN-γ-mediated increase in CD40 expression and activation suppress neurotoxic inflammasome activation required for Th17 response. Collectively, the findings indicate that CD40 is a novel negative regulator of ATP-TLR4-mediated inflammasome activation in microglia, thus providing a checkpoint to regulate excessive inflammasome activation and Th17 response during DAMP-mediated brain injury.

Entities:  

Keywords:  ATP/DAMPs; CD40; Inflammasome; Microglia; T cells; TLR4

Mesh:

Substances:

Year:  2016        PMID: 26961545     DOI: 10.1007/s10571-016-0358-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  45 in total

1.  Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction.

Authors:  Chong-Shan Shi; Kevin Shenderov; Ning-Na Huang; Juraj Kabat; Mones Abu-Asab; Katherine A Fitzgerald; Alan Sher; John H Kehrl
Journal:  Nat Immunol       Date:  2012-01-29       Impact factor: 25.606

2.  Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages.

Authors:  V T Nguyen; E N Benveniste
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

3.  Expression of interleukin-17 in ischemic brain tissue.

Authors:  G-Z Li; D Zhong; L-M Yang; B Sun; Z-H Zhong; Y-H Yin; J Cheng; B-B Yan; H-L Li
Journal:  Scand J Immunol       Date:  2005-11       Impact factor: 3.487

4.  LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia.

Authors:  Hongwei Qin; Cynthia A Wilson; Sun Jung Lee; Xueyan Zhao; Etty N Benveniste
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

Review 5.  Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.

Authors:  Edward Beamer; Flóra Gölöncsér; Gergely Horváth; Katinka Bekő; Lilla Otrokocsi; Bence Koványi; Beáta Sperlágh
Journal:  Neuropharmacology       Date:  2015-09-16       Impact factor: 5.250

Review 6.  Biological role of Toll-like receptor-4 in the brain.

Authors:  Teresa Trotta; Chiara Porro; Rosa Calvello; Maria Antonietta Panaro
Journal:  J Neuroimmunol       Date:  2014-02-04       Impact factor: 3.478

7.  Rapid disease development in scrapie-infected mice deficient for CD40 ligand.

Authors:  Michael Burwinkel; Anja Schwarz; Constanze Riemer; Julia Schultz; Frank van Landeghem; Michael Baier
Journal:  EMBO Rep       Date:  2004-04-08       Impact factor: 8.807

8.  Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.

Authors:  D Yang-Wei Fann; S Y Lee; S Manzanero; S C Tang; M Gelderblom; P Chunduri; C Bernreuther; M Glatzel; Y L Cheng; J Thundyil; A Widiapradja; K Z Lok; S L Foo; Y C Wang; Y I Li; G R Drummond; M Basta; T Magnus; D G Jo; M P Mattson; C G Sobey; T V Arumugam
Journal:  Cell Death Dis       Date:  2013-09-05       Impact factor: 8.469

9.  DAMP-Mediated Activation of NLRP3-Inflammasome in Brain Sterile Inflammation: The Fine Line between Healing and Neurodegeneration.

Authors:  Anna Rubartelli
Journal:  Front Immunol       Date:  2014-03-17       Impact factor: 7.561

10.  Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4- and MyD88-dependent pathway.

Authors:  Karen Rosenberger; Paul Dembny; Katja Derkow; Odilo Engel; Christina Krüger; Susanne A Wolf; Helmut Kettenmann; Eckart Schott; Andreas Meisel; Seija Lehnardt
Journal:  Mol Neurodegener       Date:  2015-02-26       Impact factor: 14.195

View more
  12 in total

Review 1.  Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.

Authors:  Jin Kyung Kim; Hyo Sun Jin; Hyun-Woo Suh; Eun-Kyeong Jo
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

Review 2.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

Review 3.  The Signaling Pathways Regulating NLRP3 Inflammasome Activation.

Authors:  Ming-Ye Chen; Xun-Jia Ye; Xian-Hui He; Dong-Yun Ouyang
Journal:  Inflammation       Date:  2021-05-19       Impact factor: 4.092

4.  Microglia Polarization with M1/M2 Phenotype Changes in rd1 Mouse Model of Retinal Degeneration.

Authors:  Tian Zhou; Zijing Huang; Xiaowei Sun; Xiaowei Zhu; Lingli Zhou; Mei Li; Bing Cheng; Xialin Liu; Chang He
Journal:  Front Neuroanat       Date:  2017-09-05       Impact factor: 3.856

5.  The biological clock: Future of neurological disorders therapy.

Authors:  Sagar Gaikwad
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

6.  Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome.

Authors:  Yan Deng; Sheng-Lan Guo; Bin Wei; Xing-Cui Gao; Ying-Chuan Zhou; Jia-Quan Li
Journal:  Front Pharmacol       Date:  2019-02-26       Impact factor: 5.810

Review 7.  Safety and Clinical Efficacy of Yangxue Qingnao Granules in the Treatment of Chronic Cerebral Circulation Insufficiency: A Systematic Review and Meta-Analysis.

Authors:  Jianbo Guo; Xingjiang Xiong; Yu Cao; Yukun Ding; Qingyong He
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-14       Impact factor: 2.629

Review 8.  Autophagy and inflammation in ischemic stroke.

Authors:  Yun Mo; Yin-Yi Sun; Kang-Yong Liu
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

9.  Dexmedetomidine inhibits inflammation in microglia cells under stimulation of LPS and ATP by c-Fos/NLRP3/caspase-1 cascades.

Authors:  Hu Li; Xueping Zhang; Mingfu Chen; Jianyan Chen; Tao Gao; Shanglong Yao
Journal:  EXCLI J       Date:  2018-03-22       Impact factor: 4.068

Review 10.  Connexins-Based Hemichannels/Channels and Their Relationship with Inflammation, Seizures and Epilepsy.

Authors:  Laura Medina-Ceja; Juan C Salazar-Sánchez; Jorge Ortega-Ibarra; Alberto Morales-Villagrán
Journal:  Int J Mol Sci       Date:  2019-11-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.